Effect of Abdominal Wall Injections on Abdominal Pain
Recruiting
Phase 4
Interventional Study
Anterior Cutaneous Nerve Entrapment Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 100
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 45 (estimated)
- Sponsor
- Oregon Health and Science University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a prospective cohort study of outpatient adults with chronic abdominal wall pain receiving abdominal wall injections, as part of their usual care, with lidocaine. Subjects will be recruited at the outpatient gastroenterology clinic at OHSU.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Localized abdominal wall pain
* Average daily pain (7-day recall) ≥ 3 on a scale of 0-10
* Suspected abdominal wall etiology for abdominal pain
* Positive Carnett's sign or pain near an incisional site
* 18 years of age or older
Exclusion Criteria:
* Suspected visceral etiol…
Contacts